BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32875347)

  • 1. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
    Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
    Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat.
    Dawson P; Opacka-Juffry J; Moffatt JD; Daniju Y; Dutta N; Ramsey J; Davidson C
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():57-63. PubMed ID: 24012617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.
    Marusich JA; Antonazzo KR; Blough BE; Brandt SD; Kavanagh PV; Partilla JS; Baumann MH
    Neuropharmacology; 2016 Feb; 101():68-75. PubMed ID: 26362361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
    Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of novel psychoactive benzofurans.
    Rickli A; Kopf S; Hoener MC; Liechti ME
    Br J Pharmacol; 2015 Jul; 172(13):3412-25. PubMed ID: 25765500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
    Simmler LD; Liechti ME
    Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum.
    Fuwa T; Suzuki J; Tanaka T; Inomata A; Honda Y; Kodama T
    J Toxicol Sci; 2016; 41(3):329-37. PubMed ID: 27193726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
    Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes.
    Nakagawa Y; Suzuki T; Tada Y; Inomata A
    J Appl Toxicol; 2017 Mar; 37(3):243-252. PubMed ID: 27291301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.
    Shimshoni JA; Winkler I; Golan E; Nutt D
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):15-24. PubMed ID: 27650729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
    Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
    Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eutylone and Its Structural Isomers Interact with Monoamine Transporters and Induce Locomotor Stimulation.
    Glatfelter GC; Walther D; Evans-Brown M; Baumann MH
    ACS Chem Neurosci; 2021 Apr; 12(7):1170-1177. PubMed ID: 33689284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates.
    Saha K; Li Y; Holy M; Lehner KR; Bukhari MO; Partilla JS; Sandtner W; Sitte HH; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):953-962. PubMed ID: 30345459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine.
    Johnson CB; Walther D; Baggott MJ; Baker LE; Baumann MH
    J Pharmacol Exp Ther; 2024 Jan; ():. PubMed ID: 38272669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotor and discriminative stimulus effects of three benzofuran compounds in comparison to abused psychostimulants.
    Hill RD; Shetty RA; Sumien N; Forster MJ; Gatch MB
    Drug Alcohol Depend Rep; 2023 Sep; 8():100182. PubMed ID: 37600151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.